Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

Update Il y a 4 ans
Reference: NCT02044653

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of study is - Part A : To explore the optimal fixed starting dose and dosing interval of GX-E2 - Part B : To evaluate the proof of concept (POC) of GX-E2


Inclusion criteria

  • Anemia,chronic kidney disease

Links